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ABSTRACT 
Objective: The main objective of the present study was to evaluate the anti-inflammatory activity of isolated bioactive flavonoid Mesuaferrin-A 
from the bark of Mesuaferrea L. by in vitro, in vivo and in silico approach.  
Methods: To evaluate the effect of isolated bioactive flavonoid Mesuaferrin-A on arachidonic acid metabolizing enzymes (PLA2, COX-2 and 5-LOX) 
using in vitro methods, followed by carrageenan-induced paw edema model by in vivo and to determine the binding orientation and interactions of 
Mesuaferrin-A onarachidonic acid metabolizing enzymes (PLA2, COX-2 and 5-LOX) crystal proteins using molecular docking (in silico) studies. 
Results: Mesuaferrin-A exhibited a dose-dependent significant 5-LOX inhibitory and considerable COX-2 inhibitory activity by in vitro, The 
inhibitory activities of 5-LOX and COX-2 at 100µg/ml were found to be 78.67%, 81.03% with IC50 values of 45.22µg/ml and 35.74µg/ml 
respectively. Whereas Mesuaferrin-A showed less PLA2 inhibitory activity. Mesuaferrin-A showed 68.34% inhibitory activity at 400 mg/kg body 
weight at the late phase of carrageenan-induced paw edema, and In silico studies demonstrated that Mesuaferrin-A strongly binds with 5-LOX and 
COX-2, these strong binding affinity of Mesuaferrin-A on active site amino acids of 5-LOX and COX-2 may be responsible for inhibition of enzyme 
activity. Mesuaferrin-A showeda comparable 5-LOX and COX-2 inhibition activity with (positive control). 
Conclusion: It was concluded that Mesuaferrin-A act as 5-LOX and COX dual inhibitor, from the results it was suggests that Mesuaferrin-A, may be 
an effective preventive and therapeutic approach for patients with inflammatory-related diseases. 
Keywords: Mesuaferrin-A, Phospholipase-A2(PLA2), 5-Lipooxygenase (5-LOX), Cyclooxygenase-2 (COX-2), Generic Evolutionary Method for 
molecular Docking (GEM Dock). 




Inflammation is an innate immune response activated by a variety of 
factors such as physical and chemical factors, immunological 
reactions, microbial infections, and tissue damage [1]. Its main 
functions are to protect the body against a wide variety of harmful 
agents and to promote the renewal of normal tissue. During 
inflammation up-regulation of inflammatory macrophages releases 
of pro-inflammatory mediators, such as nitric oxide (NO), 
prostaglandin E2 (PGE2), and various cytokines, in response to 
activation signals, include chemical mediators, cytokines, and 
bacterial lipopolysaccharide (LPS) [2]. The inflammatory response 
in the host is important for interruption and resolution of the 
infectious diseases, but it is also often responsible for the signs and 
symptoms of the disease [3]. 
Arachidonic acid (AA) pathway is an important pathway in which 
phospholipase A2 (PLA2), cyclooxygenases (COXS) and lipoxygenase 
(LOX) and cytochrome P450 monooxygenases are act on 
phospholipids of membrane system and produce respective 
metabolites lysophospholipids, prostanoids, leukotrienes (LTs), 
hydroxyl eicosanoitetraic acids and epoxy eicosanoid tetraic acids 
are involved in normal and various pathophysiological functions[4]. 
Understanding the role of AA pathway in several inflammatory-
related diseases, considerable efforts are being made to the 
discovery and development of inhibitors of AA pathway as 
inflammatory preventive and therapeutic agents. Non-steroid anti-
inflammatory drugs (NSAIDs) have been explored as chemo 
preventive agents for several cancers. Though, several side effects 
associated with usage of NSAIDs hindered their clinical applications. 
Therefore, naturally occurring anti-inflammatory agents with a high 
therapeutic index and less side-effects are required as substitutes 
for synthetic anti-inflammatory drugs. Mesua ferrea L. had been used 
as traditional medicine for treatment of inflammatory related 
diseases such as arthritis, leprosy and cancer. There are only few 
studies reported on anti-inflammatory activities of Mesua ferrea L. 
From the literature, phytochemical analysis of Mesua ferrea L. bark 
extract, showed the presence of secondary metabolites such as 
flavonoids, terpenoids, glycosides, steroids, quinones and coumarins 
[5]. Narendra Prasad et al., [6] reported that ethanolic leaf extract of 
Mesua ferrea L. has shown potent antioxidant activities (DPPH, ABTS 
and NBT). Pinkesh et al., [7] reported that in vivo carrageenan-
induced rat paw edema is significantly inhibited by ethanolic 
extracts of Mesua ferrea L. flowers. No further work has been carried 
out on the isolated bioactive flavonoid Mesuaferrin A. Hence the 
present study was to evaluate the anti-inflammatory activity of 
isolated bioactive flavonoid Mesuaferrin-A by in vitro, in vivo and in 
silico approach for the development of novel therapeutic plant 
derived anti-inflammatory agents. 
MATERIALS AND METHODS 
Chemicals and materials 
PLA2, and COX-2 kits from Cayman chemical company, Ann Arbor, 
Michigan, USA. 5-LOX from Invitrogen, USA. All other reagents used 
in this study were of analytical grade. 
Phospholipase A2 assay 
PLA2 assay was performed using sPLA2 enzyme inhibitory kit for 
assessing of anti-PLA2 activity of Mesuaferrin-A. This assay was 
performed as per the instructions of the manufacturer. The reaction 
mixture is a combination of 10 µl of PLA2, 25, 50 and 100µg/ml of 
Mesuaferrin-A and 200 µl substrate. The whole reaction mixture was 
International Journal of Pharmacy and Pharmaceutical Sciences 
ISSN- 0975-1491               Vol 10, Issue 2, 2018 
Krishna et al. Int J Pharm Pharm Sci, Vol 10, Issue 2, 102-106 
 
103 
incubated for 15 min, after incubation, 10 µl of 5, 5’-dithio-bis’ 2-
nitrobenzoic acid (DTNB) was added to develop color and color is 
read at a wavelength of 415 nm. After hydrolysis of the thioester 
bond at the sn-2 position of diheptanoylthio-Phosphatidyl Choline 
(PC) (substrate) by PLA2, the free thiols were detected using DTNB, 
which has an absorbance at 415 nm. The control wells contain only 
PLA2, substrate and DTNB. Thioetheramide-PC was used as positive 
control. The percentage of inhibition of enzyme activity was 
calculated using the below formula. 
% Inhibition =  O. D. of control − O. D. of test
O. D. of control  × 100 
Cyclooxygenase (cox-2) assay  
The COX-2 inhibitory assay was performed using a colorimetric 
COX-2 inhibitory assay kit for screening of COX-2 inhibitory activity 
of Mesuaferrin-A. This assay was performed according to the 
modified chromogenic method, using N, N, N|, N|-para tetra methyl-
phenylenediamine (TMPD). Assay mixtures containing a COX-2 
enzyme (100µg), hematin (15 mmol), EDTA (3 mmol) and 25, 50 
and 100 µg/ml of Mesuaferrin-A and 100 mmol Tris HCL buffer (pH 
8.0). The assay mixture was pre-incubated for 1 min at 25 °C. The 
Reaction is activated by adding a sufficient amount of substrate 
arachidonic acid and TMPD. TMPD is oxidized during the reduction 
of prostaglandin G2 to prostaglandin H2 by the activity of COX-2. The 
oxidation of TMPD represents the enzyme activity and measured at 
603 nm using a spectrophotometer. 
% Inhibition =  O. D. of control − O. D. of test
O. D. of control  × 100 
5-Lipoxygenase (5-LOX) inhibition assay  
The anti-inflammatory activity of Mesuaferrin-A was determined 
using in vitro 5-LOX inhibition assay. This assay analyses the 
inhibitory activity against the 5-LOX enzyme, which is involved in 
the synthesis of inflammatory mediators known as leukotrienes. 
This assay was first developed by [8], later it is modified by [9]. 
Lipoxygenases are a group of dioxygenases which are involved in 
the insertion of molecular oxygen into proinflammatory ω-6 fatty 
acids such as arachidonic acid and linoleic acid. Leukotrienes are 
formed from the initial attack on arachidonic acid by 5-lipoxygenase 
which adds molecular oxygen to carbon 5, leading to the formation 
of hydroperoxyeicosatetraenoic acid (5-HPETE), dehydration of 5-
HPETE gives the epoxide, these epoxides then undergoes 
isomerisation of their double bonds and gives leukotriene A4 
(LTA4). Hydrolysis of LTA4 leads to the formation of stable LTB4. 
Linoleic acid is used as a substrate for the determination of 5-LOX 
enzyme inhibition assay because it shares a structural resemblance 
with arachidonic acid [10]. The increase in absorbance at 234 nm is 
due to the formation of 1, 3-diene from 1, 4-diene in linoleic acid 
hydroperoxide which is used in the determination of 5-lipoxygenase 
inhibitory assay. 
Mesuaferrin-A is tested at different concentrations viz., 25, 50 and 
100µg/ml. The activity of 5-Lipoxygenase was compared with the 
standard positive control Zileuton. 
The percentage inhibition of 5-lipoxygenase inhibitory activity of 
Mesuaferrin-A was calculated by using a formula.  
 
Assessment of anti-inflammatory activity 
For screening and assessment of anti-inflammatory compounds, 
carrageenan-induced paw edema is widely used animal model for 
acute inflammation and was introduced by [11]. Carrageenan is a 
mucopolysaccharide, derived from Iris sea moss, produce non-
immunological edema. There are two phases of carrageenan-
induced inflammatory reactions, i.e. Initial phase and late phase. The 
initial phase (1-3h) involves the release of histamine, serotonin and 
kinins from mast cells responsible for swelling and pain [12]. During 
the late phase (4-5 h) two important inflammatory mediators such 
as prostaglandin E2 (PGE2) and leukotriene B4 are synthesized from 
arachidonic acid-dependent pathways by cyclooxygenase-2 (COX-2) 
and 5-lipoxygenase (5-LOX) enzymatic system involved with the 
commencement of inflammatory reactions. 
Anti-inflammatory effect of Mesuaferrin-A on carrageenan-
induced inflammation in Wistar rats 
Carrageenan-induced paw edema used for the evaluation of the anti-
inflammatory activity. Male Wistar albino rats weighing 160-180 g 
were obtained from M/s Mahavir Enterprises (Hyderabad, Andhra 
Pradesh, India). The animals were fed with standard laboratory diet, 
which was purchased from M/s Rayan’s Biotechnology Pvt. Ltd. 
(Hyderabad, Andhra Pradesh, India) during the experiment the rats 
were fed with water and food adlibitum. Animal experiments were 
conducted according to CPCSEA guidelines. The Animal 
experimental protocol was approved by the Institutional Animal 
Ethical Committee (IAEC) of GITAM University (IAEC no. 517/ IAEC/ 
2012). 
The animals were divided into four groups each group containing six 
animals (n=6). The first group was given normal saline by 
intragastric catheter tube (IGC), the second, and third groups (200 
and 400 mg/kg body weight) received the Mesuaferrin-A isolated 
bioactive flavonoid for 10 d and the forth group received diclofenac 
sodium as a standard (10 mg/kg body weight). The paw volume was 
measured plethysommetrically (ug obasile, Italy) at 0h, 1h, 2h, 3h, 
4h, and 5h after the injection of carrageenan. The percentage of 
inhibition of paw volume of treated groups was calculated by 
comparing with a mean paw volume of the control group. 
 
Molecular docking studies of mesuaferrin-A on 5-LOX I GEM dock 
The X-Ray crystal structure of protein 5-lipoxygenase (PDB ID: 
308Y), COX-2 (PDB ID: 4COX) and PLA2 (PDB: 1DB5) used in docking 
studies were retrieved from Protein Data Bank. Co-crystallized 
ligands and water molecules were removed from target protein 
using Argus lab. Ligands are prepared using chemoffice 
(Cambridge). Energy minimization was done using molecular 
mechanics. The minimization was executed by the root mean square 
value reached below 0.001 Kcal/mol. Such energy minimized ligands 
and receptors were used for docking studies using GEMDOCK 
(Generic Evolutionary Method for molecular docking). A population 
size of 300 with 70 generations and 3 solutions were used in 
docking accuracy setting. Pymolis used for better visualization of the 
interactions. 
Statistical analysis 
The results were expressed as the mean±Standard error of the mean 
(SEM). The statistical difference between the test and control groups 
were evaluated by one-way analysis of variance (ANOVA) by Graph 
pad prism 6.0 software and followed by Dunnett's t-test.*p≤0.05, 
**p≤0.01, ***p≤0.001 represents a significant difference between the 
control with the test group. 
RESULTS AND DISCUSSION 
In general the processes of wound heal occurring in the body with 
the lapse of time is the greatest gift of nature mother to mankind. 
During this process, the body responds/reflects this process through 
different modes such as pain, swelling, raised temperature and 
erythema. In order to reduce the incidence of this process, allopathic 
doctors prescribe anti-inflammatory drugs called NSAIDs (Non-
Steroidal Anti-Inflammatory Drugs). Although these drugs provide 
temporary relief, research data suggests that it could give 
undesirable side effects such as gastric ulceration, liver damage and 
even stimulates the likelihood of getting myocardial infarction and 
stroke [13]. In this case, natural anti-inflammatory compounds are 
of immense interest and have been used to mediate the anti-
inflammatory process often with lesser side effects [14]. 
Effect of mesuaferrin-A on PLA2 activity 
Mesuaferrin-A was evaluated for PLA2 inhibitory activity with 
different doses viz., 25, 50 and 100μg/ml as per the manufacturer’s 
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directions. As shown in fig. 1the inhibitory effect of Mesuaferrin-A 
was found to be increased concentration-dependent manner. The 
percent inhibition was observed to be 15.38, 24.49 and 41.23% 
respectively. However, the inhibitory effect of Mesuaferrin-A was 
not so significant IC50-173.99μg/ml (**p≤0.01) as compared to that 
of Thio etheramide-PC whose IC50 was 6.65μg/ml. Our results also 
correlated with Apigenin-7-O-Β-D-Glucuronide Methyl Ester Isolated 
from ethyl acetate of Manilkarazapota leaves have significant 
inhibitory effects on spla2 activity [15]. 
 
 
Fig. 1: Inhibitory effect of Mesuaferrin–A against PLA2 activity 
compared with, Thioether amide-PC standard. Values are mean 
of three replicates±SEM. *p≤0.05, **p≤0.01, ***p≤0.001 
represents a significant difference compared with the 
Thioetheramide-PC (5 μg/ml) 
 
Effect of mesuaferrin-A on COX-2 activity 
Mesuaferrin-A was tested on COX-2 activity by taking different doses 
viz., 25, 50 and 100μg/ml and corresponding percentage inhibition 
obtained was found to be 29.12, 52.98 and 78.67% respectively. As 
shown in fig. 2 a dose-dependent percentage inhibition of COX-2 
activity was observed at 100μg/ml was found to be 78.67% with IC50 
value of45.22μg/ml, (***p≤0.001)while that of Diclofenac was found 
to be 3.78μg/ml. 
 
 
Fig. 2: Inhibitory Effect of Mesuaferrin–A against COX-2 activity 
compared with, Diclofenac sodium. Values are mean of three 
replicates±SEM. *p≤0.05, **p≤0.01, ***p≤0.001 represents a 
significant difference compared with the Diclofenac sodium  
(5 μg/ml) 
 
Hong et al. [16] found that curcumin inhibited AA metabolism by 
blocking the phosphorylation of cPLA2, down-regulating of COX-2 
expression and inhibiting the 5-LOX catalytic activity. Caoet al., [17] also 
reported that Senkyunolide O and cryptotanshinone were isolated from 
Ligusticumchuangxiiong and Salvia miltiorrhiza exhibited selective COX-
2 inhibitors with IC50 values of 5 and 22 μM, respectively. 
Effect of mesuaferrin-A on 5-LOX activity 
The Mesuaferrin-A was tested for 5-LOX inhibitory activity by taking 
different doses viz., 25, 50 and 100μg/ml as shown in fig. 3,a 
significant dose-dependent percentage inhibition of 5-LOX activity 
was observed at 100μg/ml was found to be 81.03% with IC50 value 
of 35.74µg/ml, (***p≤0.001), while that of standard inhibitor 
zileuton whose IC50 value was 5.09µg/ml.  
 
 
Fig. 3: Inhibitory Effect of Mesuaferrin–A against 5-LOX activity, 
values are mean of three replicates±SEM. *p≤0.05, **p≤0.01, 
***p≤0.001 represents significant difference compared with the 
zileuton (5 μg/ml) 
 
The anti-inflammatory activity of Mesuaferrin-A is possible due to 
inhibition of pro-inflammatory enzymes. Han et al. [18] reported 
that Garcinol, a polyisoprenylated benzophenone have to possess 5-
LOX inhibitory activity and suppressive effect on LTB4 production in 
cancer cells. Our results also correlated with that the bacteria 
associated with H. amboinensis having anti-inflammatory to inhibit 
the COX-1, COX-2, and sPLA2 enzymes activity. Yosie et al., [19]  
Anti-inflammatory effect of mesuaferrin-A on carrageenan-
induced acute inflammation in wistar rats 
It is well known that carrageenan-induced paw edema is 
characterized by biphasic event with the involvement of different 
inflammatory mediators. The results of the present investigations 
revealed that the flavonoid fraction isolated from the stem bark of 
Mesuaferra L. Possess significant anti-inflammatory activity against 
acute inflammatory models carrageenan-induced paw edema. 
As shown in the fig. 4, the isolated bioactive flavonoid Mesuaferrin-A 
(200 and 400 mg/kg body weight) showed 42.31% (*p≤0.05) and 53.52 
% (***p≤0.001) and 57.36 % (**p≤0.01) and 68.34% (***p≤0.001) paw 
edema inhibition at 4thh and 5thh respectively, whereas Diclofenac (10 
mg/kg body weight) showed 75.59 %(**p≤0.01), 82.70% (***p≤0.001) 
edema inhibition at 4th h and 5thh respectively. Hence it can be concluded 
that Mesuaferrin-A has shown potent anti-inflammatory activity 
comparable to standard drug Diclofenac in both early and late phases. 
Muralidhar et al., [20] reported that the flavonoid fraction isolated from 
the stem bark of Buteaonosperma significantly reduced the inflammation 
in the carrageenan-induced rat paw edema and cotton pellet induced 
granuloma in rats. Ishwar Bhat and Abhishek kumar [21] also reported 
that synthetic novel 1,5 benzodiazepine derivatives having anti-
inflammatory activities against carrageenan-induced paw edema in rats.  
It was known that levels of COX-2 and 5-LOX are more in 4th to 5th h, 
of the second phase of acute inflammation. This demonstrated that 
in vivo anti-inflammatory activity of Mesuaferrin-A probably due to 
COX-2 and 5-LOX inhibition. 




Fig. 4: Inhibitory effect of Mesuaferrin-A on carrageenan-induced paw volume (ml) in Wistar rats, values are mean of three 
replicates±SEM.*p≤0.05, **p≤0.01, ***p≤0.001 represents significant difference compared with the Diclofenac (10 mg/kg body weight) 
 
Molecular docking studies (in silico) of isolated mesuaferrin-A 
on PLA2, 5-LOX and COX-2 crystal proteins 
Molecular docking studies demonstrated that Mesuaferrin–A showed 
good binding affinity on 5-LOX crystal protein with binding energy of-
158.67/mol and binds in the vicinity of amino acid residues (fig. 5). 
Mesuaferrin-A binds on PLA2 and COX-2 crystal protein with binding 
energies-115.49 and-136.77 respectively. In silico studies validated 
that Mesuaferrin-Astrongly binds with 5-LOX and COX-2, the strong 
binding affinity of Mesuaferrin-Aon active site amino acids of 5-LOX 
and COX may be responsible for inhibition of enzyme activity. 
From the above studies, it is quite apparent that the flavonoid 
fraction of Mesuaferrin-A isolated from Mesua ferra L. stem bark 
possesses significant anti-inflammatory activity by inhibiting 




Fig. 5: Molecular docking studies of mesuaferrin-A on 5-LOX crystal protein, A. Binding orientation of mesuaferrin-A on 5-LOX crystal 
protein. B. Interactions of mesuaferrin-A with amino acid residues of 5-LOX 
 
CONCLUSION 
The isolated bioactive falvanoid Mesuaferrin-A from Mesuaferrea L. 
bark ethyl acetate extract acts as a dual inhibitor by inhibiting 5-
LOX, COX-2 enzymes and inhibiting carrageenan-induced paw 
edema in the late phase. Mesuaferrin-A exhibited comparable anti-
inflammatory activity with standard inflammatory drugs. Hence, it 
can be concluded that to development of novel plant-derived anti-
inflammatory drugs without having side effects. 
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